PRAX Overview
Upcoming Projects (PRAX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (PRAX)
-
A Second Look: Investigating the Phase 2a clinical trial data for PRAX-628 in patients with epilepsy
Ticker: PRAX
Executed On: May 15, 2024 at 01:00 PM EDT -
Investigating the Phase 2a clinical trial data for PRAX-628 in patients with epilepsy
Ticker: PRAX
Executed On: Apr 24, 2024 at 04:00 PM EDT -
A look at the potential of Praxis' PRAX-222 in early-onset epilepsy.
Ticker: PRAX
Executed On: Feb 09, 2024 at 07:00 AM EST -
A look at the potential of Praxis' PRAX-628 in focal epilepsy.
Ticker: PRAX
Executed On: Jan 31, 2024 at 05:00 PM EST -
Exploring the potential of Praxis' PRAX-628 & PRAX-222 in focal epilepsy & early-onset epilepsy.
Ticker: PRAX
Executed On: Jan 30, 2024 at 10:00 AM EST -
A second look at the Part 1 data from the EMBRAVE study by Praxis Precision Medicine for elsunersen (PRAX-222) in patients with SCN2A-DEE
Ticker: PRAX
Executed On: Dec 01, 2023 at 11:00 AM EST -
A look at the Part 1 data from the EMBRAVE study by Praxis Precision Medicine for elsunersen (PRAX-222) in patients with SCN2A-DEE
Ticker: PRAX
Executed On: Dec 01, 2023 at 09:30 AM EST -
Discussing the essential tremor treatment landscape, specifically PRAX-944 and SAGE-324
Tickers: PRAX, SAGE
Executed On: Jul 19, 2022 at 05:15 PM EDT
Expired Projects (PRAX)
-
Understanding the data from Praxis Precision Medicines' Essential3 program for Ulixacaltamide in patients with Essential Tremors
Ticker: PRAX
Execute By: Oct 25, 2024
Upcoming & Overdue Catalysts (PRAX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (PRAX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
